

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 5.05152230 |
| 2 | cytidine catabolic process (GO:0006216) | 5.05152230 |
| 3 | cytidine deamination (GO:0009972) | 5.05152230 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.02348481 |
| 5 | DNA deamination (GO:0045006) | 4.93669255 |
| 6 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.72616645 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.62525319 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.62525319 |
| 9 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.32034351 |
| 10 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.28879521 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.27660077 |
| 12 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.19591346 |
| 13 | negative regulation of ligase activity (GO:0051352) | 4.16440861 |
| 14 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.16440861 |
| 15 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.14781737 |
| 16 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.14781737 |
| 17 | protein maturation by protein folding (GO:0022417) | 4.13522151 |
| 18 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.08330158 |
| 19 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.08330158 |
| 20 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.08330158 |
| 21 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.01489150 |
| 22 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.96579037 |
| 23 | leukocyte aggregation (GO:0070486) | 3.95870833 |
| 24 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.92808904 |
| 25 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.92808904 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.87256982 |
| 27 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.82681296 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72992625 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.67386133 |
| 30 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.56063871 |
| 31 | regulation of cellular amine metabolic process (GO:0033238) | 3.54785930 |
| 32 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.54774091 |
| 33 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.52670034 |
| 34 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.52670034 |
| 35 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52625695 |
| 36 | sequestering of actin monomers (GO:0042989) | 3.48515709 |
| 37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.42494462 |
| 38 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.39603049 |
| 39 | ribosomal small subunit assembly (GO:0000028) | 3.38036416 |
| 40 | positive regulation of ligase activity (GO:0051351) | 3.37756056 |
| 41 | positive regulation of cell cycle arrest (GO:0071158) | 3.36094541 |
| 42 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35756886 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.28447842 |
| 44 | respiratory burst (GO:0045730) | 3.26250824 |
| 45 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.20971886 |
| 46 | autophagic vacuole fusion (GO:0000046) | 3.19273056 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14663984 |
| 48 | signal peptide processing (GO:0006465) | 3.11303716 |
| 49 | negative regulation of T cell apoptotic process (GO:0070233) | 3.09751196 |
| 50 | organelle membrane fusion (GO:0090174) | 3.09735867 |
| 51 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.05089680 |
| 52 | respiratory electron transport chain (GO:0022904) | 3.04450143 |
| 53 | negative regulation of B cell apoptotic process (GO:0002903) | 3.04087621 |
| 54 | cellular response to interferon-beta (GO:0035458) | 3.03954769 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01818252 |
| 56 | establishment of viral latency (GO:0019043) | 3.00116885 |
| 57 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.98746278 |
| 58 | ATP synthesis coupled proton transport (GO:0015986) | 2.98746278 |
| 59 | electron transport chain (GO:0022900) | 2.98200450 |
| 60 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.97704772 |
| 61 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.95662925 |
| 62 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.94655734 |
| 63 | regulation of ligase activity (GO:0051340) | 2.92938098 |
| 64 | chaperone-mediated protein transport (GO:0072321) | 2.92873185 |
| 65 | cellular response to type I interferon (GO:0071357) | 2.91343020 |
| 66 | type I interferon signaling pathway (GO:0060337) | 2.91343020 |
| 67 | regulation of chronic inflammatory response (GO:0002676) | 2.91015486 |
| 68 | response to type I interferon (GO:0034340) | 2.89953758 |
| 69 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.89494950 |
| 70 | regulation of response to interferon-gamma (GO:0060330) | 2.87333579 |
| 71 | negative regulation of protein ubiquitination (GO:0031397) | 2.87318839 |
| 72 | regulation of cell cycle arrest (GO:0071156) | 2.86368866 |
| 73 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.85854773 |
| 74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.85122184 |
| 75 | T cell migration (GO:0072678) | 2.85063600 |
| 76 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.83461697 |
| 77 | positive thymic T cell selection (GO:0045059) | 2.82554632 |
| 78 | B cell mediated immunity (GO:0019724) | 2.82472545 |
| 79 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.82076295 |
| 80 | response to interferon-beta (GO:0035456) | 2.80960146 |
| 81 | signal transduction in response to DNA damage (GO:0042770) | 2.79027650 |
| 82 | negative regulation of stress fiber assembly (GO:0051497) | 2.77737892 |
| 83 | cellular response to zinc ion (GO:0071294) | 2.77293876 |
| 84 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.75800400 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.75771108 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.75245195 |
| 87 | regulation of RIG-I signaling pathway (GO:0039535) | 2.74700652 |
| 88 | neutrophil activation involved in immune response (GO:0002283) | 2.73410195 |
| 89 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.71154143 |
| 90 | NIK/NF-kappaB signaling (GO:0038061) | 2.70607387 |
| 91 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.70365536 |
| 92 | deoxyribonucleotide catabolic process (GO:0009264) | 2.69347579 |
| 93 | positive regulation of prostaglandin secretion (GO:0032308) | 2.69092669 |
| 94 | COPI coating of Golgi vesicle (GO:0048205) | 2.68537825 |
| 95 | Golgi transport vesicle coating (GO:0048200) | 2.68537825 |
| 96 | negative thymic T cell selection (GO:0045060) | 2.68258343 |
| 97 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.68149829 |
| 98 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.68149829 |
| 99 | response to peptidoglycan (GO:0032494) | 2.67899264 |
| 100 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67697517 |
| 101 | negative regulation of viral genome replication (GO:0045071) | 2.65998083 |
| 102 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.65660199 |
| 103 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.65461416 |
| 104 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.63692388 |
| 105 | negative T cell selection (GO:0043383) | 2.61643508 |
| 106 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.60423309 |
| 107 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.59821355 |
| 108 | negative regulation of phagocytosis (GO:0050765) | 2.59607088 |
| 109 | interferon-gamma production (GO:0032609) | 2.59265804 |
| 110 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.59004670 |
| 111 | positive regulation of lamellipodium assembly (GO:0010592) | 2.57046105 |
| 112 | deoxyribose phosphate catabolic process (GO:0046386) | 2.56426996 |
| 113 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.56187855 |
| 114 | base-excision repair, AP site formation (GO:0006285) | 2.55729424 |
| 115 | iron-sulfur cluster assembly (GO:0016226) | 2.55178846 |
| 116 | metallo-sulfur cluster assembly (GO:0031163) | 2.55178846 |
| 117 | cotranslational protein targeting to membrane (GO:0006613) | 2.55152693 |
| 118 | protein targeting to ER (GO:0045047) | 2.55110493 |
| 119 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.54394092 |
| 120 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.54394092 |
| 121 | cytolysis (GO:0019835) | 2.53762788 |
| 122 | cellular extravasation (GO:0045123) | 2.53718651 |
| 123 | deoxyribose phosphate metabolic process (GO:0019692) | 2.53586594 |
| 124 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.53147462 |
| 125 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.53064723 |
| 126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.51927398 |
| 127 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.49676859 |
| 128 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.49390478 |
| 129 | cellular response to interleukin-15 (GO:0071350) | 2.49375853 |
| 130 | actin nucleation (GO:0045010) | 2.49273562 |
| 131 | viral transcription (GO:0019083) | 2.49091885 |
| 132 | protein localization to endoplasmic reticulum (GO:0070972) | 2.48211545 |
| 133 | positive regulation of interferon-alpha production (GO:0032727) | 2.43207304 |
| 134 | proteasome assembly (GO:0043248) | 2.42284279 |
| 135 | regulation of B cell differentiation (GO:0045577) | 2.40721945 |
| 136 | cellular response to virus (GO:0098586) | 2.40496163 |
| 137 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.40062103 |
| 138 | translational termination (GO:0006415) | 2.39306970 |
| 139 | response to interleukin-15 (GO:0070672) | 2.38180529 |
| 140 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.37962402 |
| 141 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.36874112 |
| 142 | regulation of necroptotic process (GO:0060544) | 2.34778237 |
| 143 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.34012023 |
| 144 | telomere maintenance via recombination (GO:0000722) | 2.33587001 |
| 145 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.32343990 |
| 146 | barbed-end actin filament capping (GO:0051016) | 2.32152486 |
| 147 | thymic T cell selection (GO:0045061) | 2.31476015 |
| 148 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.31163002 |
| 149 | regulation of interferon-alpha production (GO:0032647) | 2.30289427 |
| 150 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.30113523 |
| 151 | positive regulation of macrophage differentiation (GO:0045651) | 2.29167332 |
| 152 | mast cell activation (GO:0045576) | 2.28077141 |
| 153 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.25028837 |
| 154 | GDP-mannose metabolic process (GO:0019673) | 2.23116130 |
| 155 | T cell apoptotic process (GO:0070231) | 2.22876996 |
| 156 | translational elongation (GO:0006414) | 2.22131119 |
| 157 | positive regulation of lamellipodium organization (GO:1902745) | 2.21840103 |
| 158 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.19620261 |
| 159 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.19620261 |
| 160 | cellular response to exogenous dsRNA (GO:0071360) | 2.19508743 |
| 161 | DNA strand elongation (GO:0022616) | 2.18464932 |
| 162 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.17997555 |
| 163 | positive regulation of isotype switching (GO:0045830) | 2.17504052 |
| 164 | T cell costimulation (GO:0031295) | 2.16910916 |
| 165 | ribosomal small subunit biogenesis (GO:0042274) | 2.16694394 |
| 166 | natural killer cell activation (GO:0030101) | 2.15326755 |
| 167 | regulation of necrotic cell death (GO:0010939) | 2.14563074 |
| 168 | pentose-phosphate shunt (GO:0006098) | 2.14478941 |
| 169 | lymphocyte costimulation (GO:0031294) | 2.14417050 |
| 170 | mitochondrial calcium ion transport (GO:0006851) | 2.14157044 |
| 171 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.13424589 |
| 172 | DNA replication checkpoint (GO:0000076) | 2.12697581 |
| 173 | positive regulation of B cell differentiation (GO:0045579) | 2.12422134 |
| 174 | myeloid dendritic cell activation (GO:0001773) | 2.12274498 |
| 175 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.11614785 |
| 176 | leukocyte cell-cell adhesion (GO:0007159) | 2.11593043 |
| 177 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.10142340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.67580113 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.38673226 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.96520037 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.90205849 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.83343480 |
| 6 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.59589547 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.38960230 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.38264816 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38188278 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38054935 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.33923521 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33885665 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.24820319 |
| 14 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24375626 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.16455738 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.16393214 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.14028365 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07317601 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.03924374 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03535175 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03288533 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.03249550 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99349296 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99303080 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93960786 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90508874 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.86721510 |
| 28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84920261 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.83365126 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.83218271 |
| 31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.80281102 |
| 32 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80207184 |
| 33 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77851286 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77612444 |
| 35 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.77129078 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.74829365 |
| 37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.74571994 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.73702742 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71627213 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64641305 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60345040 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.59608135 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59472309 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.58980313 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58338858 |
| 46 | * MAF_26560356_Chip-Seq_TH1_Human | 1.57994362 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.57210334 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55153600 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52353153 |
| 50 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.51864320 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50224055 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.49885955 |
| 53 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48153861 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47933770 |
| 55 | * MYB_26560356_Chip-Seq_TH1_Human | 1.47650520 |
| 56 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47104805 |
| 57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47040889 |
| 58 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.45991451 |
| 59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.45680979 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44938603 |
| 61 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43342565 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41388059 |
| 63 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.41324250 |
| 64 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39135906 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37791805 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36823879 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.36409474 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.35791974 |
| 69 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.33712767 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32801489 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.32782048 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32683846 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31677032 |
| 74 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.31271671 |
| 75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29568026 |
| 76 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29147609 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.28907829 |
| 78 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28548570 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28536137 |
| 80 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.26791322 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26750967 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26735330 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25517371 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25014703 |
| 85 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.24685349 |
| 86 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21451173 |
| 87 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.21084539 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 1.20479015 |
| 89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19031507 |
| 90 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18735249 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17894277 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17044414 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16839231 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16456099 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16036556 |
| 96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15815765 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15779375 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15661774 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13571749 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.12769299 |
| 101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12501044 |
| 102 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12450634 |
| 103 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11394152 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10194217 |
| 105 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10033561 |
| 106 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09928065 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09675306 |
| 108 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09651310 |
| 109 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09570638 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09424379 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08837738 |
| 112 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.08621680 |
| 113 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08526620 |
| 114 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08202005 |
| 115 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08157321 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07689075 |
| 117 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.07007050 |
| 118 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06863802 |
| 119 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05536446 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05209032 |
| 121 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04435279 |
| 122 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04114433 |
| 123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03151441 |
| 124 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02771281 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 0.99618826 |
| 126 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98229123 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98018233 |
| 128 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97681881 |
| 129 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97248551 |
| 130 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95517075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.67118951 |
| 2 | MP0009785_altered_susceptibility_to | 3.08378742 |
| 3 | MP0005671_abnormal_response_to | 3.02063511 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.98465612 |
| 5 | MP0003436_decreased_susceptibility_to | 2.93609113 |
| 6 | MP0000685_abnormal_immune_system | 2.84211168 |
| 7 | MP0003724_increased_susceptibility_to | 2.58216025 |
| 8 | MP0005025_abnormal_response_to | 2.52651451 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.46902895 |
| 10 | MP0001800_abnormal_humoral_immune | 2.45434836 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.44954665 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.28627434 |
| 13 | MP0002723_abnormal_immune_serum | 2.27736224 |
| 14 | MP0005387_immune_system_phenotype | 2.24500153 |
| 15 | MP0001790_abnormal_immune_system | 2.24500153 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.23505227 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.21790715 |
| 18 | MP0001819_abnormal_immune_cell | 2.20958006 |
| 19 | MP0002419_abnormal_innate_immunity | 2.17109193 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.16127731 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.08849087 |
| 22 | MP0006082_CNS_inflammation | 2.08029149 |
| 23 | MP0002398_abnormal_bone_marrow | 2.04260907 |
| 24 | MP0002405_respiratory_system_inflammati | 2.03641850 |
| 25 | MP0002006_tumorigenesis | 1.87532518 |
| 26 | MP0000716_abnormal_immune_system | 1.87220903 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.85388023 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.84929227 |
| 29 | MP0001853_heart_inflammation | 1.81771535 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.78512449 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.77718710 |
| 32 | MP0002722_abnormal_immune_system | 1.76020464 |
| 33 | MP0000490_abnormal_crypts_of | 1.75235063 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.75032868 |
| 35 | MP0003186_abnormal_redox_activity | 1.67578341 |
| 36 | MP0000858_altered_metastatic_potential | 1.66826409 |
| 37 | MP0002429_abnormal_blood_cell | 1.64498541 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.64373057 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.60290474 |
| 40 | MP0001873_stomach_inflammation | 1.56142087 |
| 41 | MP0001905_abnormal_dopamine_level | 1.53131526 |
| 42 | MP0008469_abnormal_protein_level | 1.52544501 |
| 43 | MP0004947_skin_inflammation | 1.51699176 |
| 44 | MP0009840_abnormal_foam_cell | 1.50686677 |
| 45 | MP0005451_abnormal_body_composition | 1.48091817 |
| 46 | MP0004510_myositis | 1.47365873 |
| 47 | MP0008260_abnormal_autophagy | 1.46808272 |
| 48 | MP0005166_decreased_susceptibility_to | 1.43979315 |
| 49 | MP0003303_peritoneal_inflammation | 1.42642910 |
| 50 | MP0004957_abnormal_blastocyst_morpholog | 1.41066332 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.40417314 |
| 52 | MP0002132_abnormal_respiratory_system | 1.40095553 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.39558282 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.39183563 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.39183563 |
| 56 | MP0003075_altered_response_to | 1.39128329 |
| 57 | MP0005310_abnormal_salivary_gland | 1.39117845 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.36977754 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.36246892 |
| 60 | MP0003866_abnormal_defecation | 1.34144550 |
| 61 | MP0003077_abnormal_cell_cycle | 1.33265520 |
| 62 | MP0002933_joint_inflammation | 1.31047022 |
| 63 | MP0002019_abnormal_tumor_incidence | 1.25629517 |
| 64 | MP0009764_decreased_sensitivity_to | 1.25598423 |
| 65 | MP0000343_altered_response_to | 1.20692362 |
| 66 | MP0003111_abnormal_nucleus_morphology | 1.17745482 |
| 67 | MP0010094_abnormal_chromosome_stability | 1.14224611 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.08632365 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.06935626 |
| 70 | MP0001764_abnormal_homeostasis | 1.05065013 |
| 71 | MP0001881_abnormal_mammary_gland | 1.04333336 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 1.03901117 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.03602991 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.03553018 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.02816738 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.01700803 |
| 77 | MP0005165_increased_susceptibility_to | 1.00537658 |
| 78 | MP0005360_urolithiasis | 0.98116732 |
| 79 | MP0003448_altered_tumor_morphology | 0.95819807 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.95294136 |
| 81 | MP0000609_abnormal_liver_physiology | 0.93770629 |
| 82 | MP0008872_abnormal_physiological_respon | 0.93271919 |
| 83 | MP0009763_increased_sensitivity_to | 0.93243781 |
| 84 | MP0001727_abnormal_embryo_implantation | 0.92125168 |
| 85 | MP0003300_gastrointestinal_ulcer | 0.91392790 |
| 86 | MP0008873_increased_physiological_sensi | 0.91108678 |
| 87 | MP0005023_abnormal_wound_healing | 0.90747357 |
| 88 | MP0004381_abnormal_hair_follicle | 0.88243737 |
| 89 | MP0005365_abnormal_bile_salt | 0.87558371 |
| 90 | MP0008007_abnormal_cellular_replicative | 0.84813507 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84514383 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.83235923 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.82453649 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.82350560 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.82213051 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.81917874 |
| 97 | MP0008058_abnormal_DNA_repair | 0.81478313 |
| 98 | MP0009278_abnormal_bone_marrow | 0.78676897 |
| 99 | MP0001851_eye_inflammation | 0.78347428 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.77408250 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 0.76970919 |
| 102 | MP0000598_abnormal_liver_morphology | 0.74698450 |
| 103 | MP0002653_abnormal_ependyma_morphology | 0.73691932 |
| 104 | MP0002876_abnormal_thyroid_physiology | 0.72653227 |
| 105 | MP0005220_abnormal_exocrine_pancreas | 0.72571023 |
| 106 | MP0000313_abnormal_cell_death | 0.72210455 |
| 107 | MP0005410_abnormal_fertilization | 0.72078552 |
| 108 | MP0006054_spinal_hemorrhage | 0.70932438 |
| 109 | MP0008932_abnormal_embryonic_tissue | 0.70683871 |
| 110 | MP0005501_abnormal_skin_physiology | 0.69049522 |
| 111 | MP0000477_abnormal_intestine_morphology | 0.68813254 |
| 112 | MP0005084_abnormal_gallbladder_morpholo | 0.67589231 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.67392018 |
| 114 | MP0005083_abnormal_biliary_tract | 0.66623162 |
| 115 | MP0005395_other_phenotype | 0.66411835 |
| 116 | MP0003786_premature_aging | 0.65192639 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.65086340 |
| 118 | MP0001663_abnormal_digestive_system | 0.64877194 |
| 119 | MP0003718_maternal_effect | 0.64012000 |
| 120 | MP0002163_abnormal_gland_morphology | 0.63260286 |
| 121 | MP0001666_abnormal_nutrient_absorption | 0.63082374 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.62321253 |
| 123 | MP0000358_abnormal_cell_content/ | 0.61241373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.75574131 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.50085111 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.29473682 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.87826515 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.78522036 |
| 6 | Myositis (HP:0100614) | 3.78161714 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.74661912 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.73442399 |
| 9 | IgM deficiency (HP:0002850) | 3.65881898 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.64538892 |
| 11 | Recurrent bronchitis (HP:0002837) | 3.50633958 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.47054049 |
| 13 | Hepatic necrosis (HP:0002605) | 3.41614784 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.33531733 |
| 15 | Combined immunodeficiency (HP:0005387) | 3.29929010 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.25454243 |
| 17 | Abnormality of T cells (HP:0002843) | 3.24444812 |
| 18 | Increased CSF lactate (HP:0002490) | 3.15941974 |
| 19 | Abnormality of T cell physiology (HP:0011840) | 3.15622519 |
| 20 | Thrombocytosis (HP:0001894) | 3.14371800 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.11892855 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 3.10399788 |
| 23 | Acute encephalopathy (HP:0006846) | 3.09992883 |
| 24 | T lymphocytopenia (HP:0005403) | 3.08926557 |
| 25 | Cerebral palsy (HP:0100021) | 3.07646649 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07132715 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07132715 |
| 28 | Pustule (HP:0200039) | 3.04932599 |
| 29 | Recurrent skin infections (HP:0001581) | 3.03172283 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.99720821 |
| 31 | Petechiae (HP:0000967) | 2.94148846 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 2.90594791 |
| 33 | Cholecystitis (HP:0001082) | 2.88200965 |
| 34 | Abnormal gallbladder physiology (HP:0012438) | 2.88200965 |
| 35 | Recurrent viral infections (HP:0004429) | 2.85793058 |
| 36 | Progressive macrocephaly (HP:0004481) | 2.83500352 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.82513411 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.82417596 |
| 39 | IgG deficiency (HP:0004315) | 2.80643603 |
| 40 | Chronic otitis media (HP:0000389) | 2.78915564 |
| 41 | Hypokinesia (HP:0002375) | 2.78061898 |
| 42 | Cerebral edema (HP:0002181) | 2.72882636 |
| 43 | Increased IgM level (HP:0003496) | 2.70922350 |
| 44 | Orchitis (HP:0100796) | 2.69201956 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.68960985 |
| 46 | Meningitis (HP:0001287) | 2.68689662 |
| 47 | Abnormality of B cell number (HP:0010975) | 2.64547164 |
| 48 | B lymphocytopenia (HP:0010976) | 2.64547164 |
| 49 | Aplastic anemia (HP:0001915) | 2.63366895 |
| 50 | Pancytopenia (HP:0001876) | 2.61971396 |
| 51 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.61879789 |
| 52 | Nasal polyposis (HP:0100582) | 2.59867003 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.59499998 |
| 54 | Obstructive lung disease (HP:0006536) | 2.58592128 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58592128 |
| 56 | Lymphopenia (HP:0001888) | 2.57781267 |
| 57 | Renal Fanconi syndrome (HP:0001994) | 2.57206327 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.55283974 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.55143299 |
| 60 | Hypoproteinemia (HP:0003075) | 2.54779167 |
| 61 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.49903843 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.49428157 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49428157 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.48620313 |
| 65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.47515347 |
| 66 | 3-Methylglutaconic aciduria (HP:0003535) | 2.47332535 |
| 67 | Rough bone trabeculation (HP:0100670) | 2.46543101 |
| 68 | Type I transferrin isoform profile (HP:0003642) | 2.45178830 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.45042656 |
| 70 | Stomatitis (HP:0010280) | 2.44922949 |
| 71 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.43319885 |
| 72 | Lactic acidosis (HP:0003128) | 2.42087555 |
| 73 | Vasculitis (HP:0002633) | 2.41583677 |
| 74 | Exercise intolerance (HP:0003546) | 2.40773518 |
| 75 | Panhypogammaglobulinemia (HP:0003139) | 2.39161364 |
| 76 | Poor head control (HP:0002421) | 2.39019117 |
| 77 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.37802631 |
| 78 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.37802631 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.35115627 |
| 80 | Abnormal number of erythroid precursors (HP:0012131) | 2.34091751 |
| 81 | Urticaria (HP:0001025) | 2.31750737 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.31632301 |
| 83 | Increased serum lactate (HP:0002151) | 2.31175905 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.30976060 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.30860204 |
| 86 | Gingivitis (HP:0000230) | 2.30198021 |
| 87 | Microcytic anemia (HP:0001935) | 2.29713474 |
| 88 | Lipid accumulation in hepatocytes (HP:0006561) | 2.28507334 |
| 89 | Leukocytosis (HP:0001974) | 2.26518808 |
| 90 | Autoimmune hemolytic anemia (HP:0001890) | 2.24655174 |
| 91 | Bronchitis (HP:0012387) | 2.22514095 |
| 92 | Retrobulbar optic neuritis (HP:0100654) | 2.22422638 |
| 93 | Optic neuritis (HP:0100653) | 2.22422638 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22224789 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22224789 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22224789 |
| 97 | Cellulitis (HP:0100658) | 2.20501977 |
| 98 | Abnormality of eosinophils (HP:0001879) | 2.20203882 |
| 99 | Testicular atrophy (HP:0000029) | 2.20146358 |
| 100 | Abnormal protein glycosylation (HP:0012346) | 2.18596276 |
| 101 | Abnormal glycosylation (HP:0012345) | 2.18596276 |
| 102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.18596276 |
| 103 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.18596276 |
| 104 | Hypertensive crisis (HP:0100735) | 2.14847882 |
| 105 | Hemoptysis (HP:0002105) | 2.14557425 |
| 106 | Epistaxis (HP:0000421) | 2.14398442 |
| 107 | Thyroiditis (HP:0100646) | 2.14300859 |
| 108 | Granulocytopenia (HP:0001913) | 2.14267427 |
| 109 | Acute hepatic failure (HP:0006554) | 2.13649264 |
| 110 | Reticulocytopenia (HP:0001896) | 2.13120484 |
| 111 | Respiratory failure (HP:0002878) | 2.11090813 |
| 112 | Hypoplasia of the thymus (HP:0000778) | 2.10508329 |
| 113 | Microvesicular hepatic steatosis (HP:0001414) | 2.05653468 |
| 114 | Recurrent sinusitis (HP:0011108) | 2.05295220 |
| 115 | Chronic diarrhea (HP:0002028) | 2.02596106 |
| 116 | Abnormality of the prostate (HP:0008775) | 2.02583821 |
| 117 | Generalized aminoaciduria (HP:0002909) | 2.01398930 |
| 118 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.01173810 |
| 119 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99936086 |
| 120 | Encephalitis (HP:0002383) | 1.99410293 |
| 121 | Exertional dyspnea (HP:0002875) | 1.98311775 |
| 122 | Eosinophilia (HP:0001880) | 1.98009631 |
| 123 | Poikiloderma (HP:0001029) | 1.97349602 |
| 124 | Pulmonary infiltrates (HP:0002113) | 1.97325012 |
| 125 | Lymphoma (HP:0002665) | 1.97254470 |
| 126 | Neutropenia (HP:0001875) | 1.96301626 |
| 127 | Joint swelling (HP:0001386) | 1.96031390 |
| 128 | Multiple enchondromatosis (HP:0005701) | 1.95848218 |
| 129 | Skin rash (HP:0000988) | 1.95615384 |
| 130 | Microretrognathia (HP:0000308) | 1.94398485 |
| 131 | Emotional lability (HP:0000712) | 1.93919043 |
| 132 | Oral leukoplakia (HP:0002745) | 1.93845750 |
| 133 | Seborrheic dermatitis (HP:0001051) | 1.92383488 |
| 134 | Cheilitis (HP:0100825) | 1.91681469 |
| 135 | Gastrointestinal inflammation (HP:0004386) | 1.90324668 |
| 136 | Gingival bleeding (HP:0000225) | 1.90229940 |
| 137 | Recurrent pneumonia (HP:0006532) | 1.89685441 |
| 138 | Growth hormone excess (HP:0000845) | 1.89027691 |
| 139 | Gastrointestinal infarctions (HP:0005244) | 1.88673815 |
| 140 | Purpura (HP:0000979) | 1.88435950 |
| 141 | Spontaneous hematomas (HP:0007420) | 1.88219292 |
| 142 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.86854165 |
| 143 | Sparse eyelashes (HP:0000653) | 1.85856271 |
| 144 | Inflammation of the large intestine (HP:0002037) | 1.85345565 |
| 145 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.85066366 |
| 146 | Skin ulcer (HP:0200042) | 1.84339992 |
| 147 | Periodontitis (HP:0000704) | 1.83031662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.21450292 |
| 2 | MAP4K1 | 3.84946438 |
| 3 | ERN1 | 3.23199655 |
| 4 | NME2 | 2.73585327 |
| 5 | BLK | 2.68802824 |
| 6 | TXK | 2.66798881 |
| 7 | ZAP70 | 2.64762100 |
| 8 | LIMK1 | 2.41600087 |
| 9 | BUB1 | 2.39329439 |
| 10 | KDR | 2.38616580 |
| 11 | TYK2 | 2.33536926 |
| 12 | TESK2 | 2.30983890 |
| 13 | TBK1 | 2.30457830 |
| 14 | IKBKE | 2.27707889 |
| 15 | JAK3 | 2.21401879 |
| 16 | EIF2AK1 | 2.16902986 |
| 17 | IRAK4 | 2.10792694 |
| 18 | EIF2AK3 | 1.89671459 |
| 19 | TAOK3 | 1.88165614 |
| 20 | KIT | 1.86370119 |
| 21 | TEC | 1.78378079 |
| 22 | PIM2 | 1.73730319 |
| 23 | EPHA2 | 1.69573635 |
| 24 | BTK | 1.63981281 |
| 25 | STK10 | 1.62956026 |
| 26 | FGFR4 | 1.59301443 |
| 27 | STK16 | 1.54787167 |
| 28 | NLK | 1.52878277 |
| 29 | IRAK3 | 1.45902360 |
| 30 | RPS6KA4 | 1.45589321 |
| 31 | ACVR1B | 1.37556200 |
| 32 | FLT3 | 1.33433970 |
| 33 | MAP2K3 | 1.32667902 |
| 34 | MAP3K14 | 1.32148424 |
| 35 | MAP3K12 | 1.30659698 |
| 36 | DAPK1 | 1.28121789 |
| 37 | NME1 | 1.27824365 |
| 38 | BCKDK | 1.26284797 |
| 39 | ARAF | 1.26116400 |
| 40 | MAP3K11 | 1.23737143 |
| 41 | MOS | 1.21276591 |
| 42 | GRK6 | 1.20587983 |
| 43 | PLK4 | 1.19346148 |
| 44 | SYK | 1.19000023 |
| 45 | ITK | 1.16043632 |
| 46 | TAOK2 | 1.15159873 |
| 47 | MAPKAPK3 | 1.13063242 |
| 48 | IKBKB | 1.10970832 |
| 49 | JAK1 | 1.09815857 |
| 50 | MAP3K10 | 1.06751033 |
| 51 | FES | 1.03785289 |
| 52 | MAP3K13 | 1.02841796 |
| 53 | CSK | 1.00840309 |
| 54 | TNK2 | 0.97829880 |
| 55 | PIM1 | 0.97582070 |
| 56 | LRRK2 | 0.94581554 |
| 57 | AURKA | 0.94421506 |
| 58 | LCK | 0.94054675 |
| 59 | NEK2 | 0.90576317 |
| 60 | ABL2 | 0.87343095 |
| 61 | TESK1 | 0.87326108 |
| 62 | CSF1R | 0.85988487 |
| 63 | LYN | 0.85846479 |
| 64 | MAPK11 | 0.82894422 |
| 65 | RAF1 | 0.81770820 |
| 66 | CSNK1G3 | 0.79809164 |
| 67 | VRK1 | 0.76114924 |
| 68 | PRKCI | 0.75706489 |
| 69 | PKN2 | 0.74695403 |
| 70 | TGFBR2 | 0.74422824 |
| 71 | TAOK1 | 0.74067307 |
| 72 | RIPK4 | 0.72753656 |
| 73 | PAK1 | 0.72431215 |
| 74 | NEK9 | 0.71434324 |
| 75 | MAP3K3 | 0.70780978 |
| 76 | HCK | 0.70379315 |
| 77 | TRIB3 | 0.68403096 |
| 78 | SCYL2 | 0.68222167 |
| 79 | CDK8 | 0.66327323 |
| 80 | MST4 | 0.66073395 |
| 81 | PAK4 | 0.65726321 |
| 82 | TLK1 | 0.65203449 |
| 83 | RPS6KB2 | 0.64939311 |
| 84 | PRKCQ | 0.64676234 |
| 85 | GRK7 | 0.64180932 |
| 86 | WEE1 | 0.63996179 |
| 87 | JAK2 | 0.63985929 |
| 88 | LMTK2 | 0.63899959 |
| 89 | PBK | 0.62824143 |
| 90 | MAP4K2 | 0.62026443 |
| 91 | SRPK1 | 0.60900986 |
| 92 | BRAF | 0.60458540 |
| 93 | MAP3K8 | 0.60265575 |
| 94 | EEF2K | 0.60250576 |
| 95 | CHUK | 0.58194272 |
| 96 | MUSK | 0.57984241 |
| 97 | STK4 | 0.57526504 |
| 98 | AURKB | 0.56382095 |
| 99 | CDK4 | 0.55672621 |
| 100 | BRSK2 | 0.55197580 |
| 101 | MST1R | 0.55128926 |
| 102 | PRKG2 | 0.53848959 |
| 103 | CDC7 | 0.52853469 |
| 104 | ILK | 0.52101962 |
| 105 | SMG1 | 0.51546863 |
| 106 | ZAK | 0.51254681 |
| 107 | DYRK3 | 0.50888020 |
| 108 | NEK1 | 0.46840885 |
| 109 | MAP2K2 | 0.46542749 |
| 110 | GRK5 | 0.46310123 |
| 111 | BRSK1 | 0.46033710 |
| 112 | CDK7 | 0.45988194 |
| 113 | BMPR2 | 0.44621873 |
| 114 | MARK3 | 0.44616764 |
| 115 | CLK1 | 0.44542406 |
| 116 | PLK1 | 0.43418034 |
| 117 | CSNK1G1 | 0.42119666 |
| 118 | HIPK2 | 0.41842977 |
| 119 | MAP3K6 | 0.41002673 |
| 120 | MYLK | 0.40871313 |
| 121 | EIF2AK2 | 0.39025846 |
| 122 | MAP3K9 | 0.39010445 |
| 123 | CSNK1A1L | 0.37495892 |
| 124 | RPS6KA5 | 0.37389999 |
| 125 | FGFR3 | 0.36139433 |
| 126 | MAPKAPK2 | 0.34961098 |
| 127 | CDK9 | 0.33788567 |
| 128 | PRKCD | 0.32302232 |
| 129 | MAP2K6 | 0.31217395 |
| 130 | SIK3 | 0.31154029 |
| 131 | CSNK1G2 | 0.30442213 |
| 132 | CAMK2G | 0.30089838 |
| 133 | DAPK3 | 0.29479914 |
| 134 | ADRBK2 | 0.28557797 |
| 135 | NUAK1 | 0.28276921 |
| 136 | CSNK2A1 | 0.27549909 |
| 137 | PRKD1 | 0.25717953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.12246854 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.86926597 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.74385105 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.58025711 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.55647191 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.52263613 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.41406522 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.33910666 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.03087615 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 1.96288074 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 1.93393080 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90868971 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.79331534 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78291273 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76311357 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.75718135 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.75032601 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.67618510 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64048964 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63730811 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63013544 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.61211270 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57492090 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.56438173 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55527518 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53088154 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50954856 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48346439 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47463160 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46027562 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.44318887 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43080586 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40966820 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.36370715 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33834161 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32855708 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32389756 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28480430 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.28200959 |
| 40 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.26803776 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26222901 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24611778 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21121466 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.20115015 |
| 45 | Cell cycle_Homo sapiens_hsa04110 | 1.14266327 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.11727900 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.10240165 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09463489 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 1.08854899 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05031493 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.04063729 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 1.02619012 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02249969 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01010737 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98648738 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.98601174 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97686052 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96782534 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.96771339 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.95781681 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93740249 |
| 62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93131662 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93107372 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92574783 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92222860 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.90168035 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.88658861 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.87698044 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.86182233 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.85611870 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82781414 |
| 72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.80592292 |
| 73 | Hepatitis B_Homo sapiens_hsa05161 | 0.79743565 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78915674 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.78134410 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77487298 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76401651 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73588773 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73035901 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72907422 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72212169 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70761327 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69573686 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.68702258 |
| 85 | RNA transport_Homo sapiens_hsa03013 | 0.68047030 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67652441 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66211817 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65719671 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64715681 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64633591 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64564680 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63966597 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62116977 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62067853 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59669136 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59416175 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.58863513 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58108094 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.56110634 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55289555 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54418371 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.53953539 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53316920 |
| 104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52616459 |
| 105 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52118168 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51806604 |
| 107 | Peroxisome_Homo sapiens_hsa04146 | 0.50869494 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50566425 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49368041 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48828686 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48576292 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48538100 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48090893 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.47846885 |
| 115 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47681317 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46955110 |
| 117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46855354 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46597056 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46583815 |
| 120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44472036 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43517525 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43241617 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42315235 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39927361 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39530836 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.39362226 |
| 127 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38693051 |
| 128 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37353944 |
| 129 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.34216413 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32411378 |
| 131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30311488 |

